Search
for
Sort by
Research 211–240 of 1000+
- Las sucesiones mortis causa transfronterizas en la Unión Europea
- Medical dermatologic conditions in transgender women
- A newly discovered linkage between proteoglycans and hair biology: decorin acts as an anagen inducer
- 549 Temporary cell cycle arrest in human scalp hair follicles and their epithelial stem cells by ALRN-6924: A novel strategy to selectively protect p53-wildtype cells against paclitaxel-induced alopecia
- Gender-affirming hair procedures
- Skin Disorders in Transgender Patients
- Traction Alopecia
- SKIN AND HAIR CHANGES AFTER FORTY
- Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
- Dissolving microneedles for alopecia treatment
- Advancements in hydrogel-based design and applications of hair follicle organoids
- Cold Atmospheric Plasma for Breast Cancer
- Can nanozymes make the leap to the clinic? Advances, hurdles, and prospects
- Exosomes in precision dermatology: From biomarkers to targeted therapeutics in personalized care
- Microneedles: A Promising Therapeutic Strategy for Next-Generation Drug Delivery, Diagnosis and Biosensing
- Frontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis
- Innovations in Stem Cell Therapy for Diabetic Wound Healing
- Foxn1 in Skin Development, Homeostasis and Wound Healing
- Revolutionizing Alopecia Treatment: Nanostructured Lipid Carriers for Herbal Bioactives in Hair Regeneration
- Tissue Engineering and Regeneration of the Human Hair Follicle in Androgenetic Alopecia: Literature Review
- Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues
- Care of the newborn with ichthyosis
- Shedding: How to manage a common cause of hair loss
- S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma
- The Latest Innovations in Hair Transplantation
- Women's midlife health Reframing menopause
- MALE PATTERN ALOPECIA
- Efficacy and safety of dual-targeted therapy for refractory inflammatory bowel disease: a retrospective case series from three tertiary general hospitals in China
- What you need to know about gender‐affirming healthcare
- Telogen Effluvium